PubRank

Bas P L Wijnhoven

Author PubWeight™ 46.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002 8.72
2 Residual esophageal cancer after neoadjuvant chemoradiotherapy frequently involves the mucosa and submucosa. Ann Surg 2013 2.79
3 End-to-end versus end-to-side esophagogastrostomy after esophageal cancer resection: a prospective randomized study. Ann Surg 2011 2.56
4 Preoperative assessment of tumor location and station-specific lymph node status in patients with adenocarcinoma of the gastroesophageal junction. World J Surg 2013 1.64
5 Validation of a nomogram predicting complications after esophagectomy for cancer. Ann Thorac Surg 2010 1.47
6 Barrett's oesophageal adenocarcinoma encompasses tumour-initiating cells that do not express common cancer stem cell markers. J Pathol 2010 1.44
7 The sentinel node concept in adenocarcinomas of the distal esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg 2009 1.39
8 Prognostic Value of Pretreatment Pathological Tumor Extent in Patients Treated With Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal or Junctional Cancer. Ann Surg 2017 1.38
9 The molecular biology of esophageal adenocarcinoma. J Surg Oncol 2005 1.32
10 Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer. Ann Surg Oncol 2012 1.29
11 The comprehensive complication index: a novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials. Ann Surg 2014 1.17
12 Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens. Ann Surg Oncol 2008 1.12
13 Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma. J Clin Oncol 2013 1.06
14 Delay in diagnostic workup and treatment of esophageal cancer. J Gastrointest Surg 2009 1.00
15 Outcome of esophagectomy for cancer in elderly patients. Ann Thorac Surg 2010 0.98
16 Preoperative risk assessment and prevention of complications in patients with esophageal cancer. J Surg Oncol 2010 0.95
17 Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival. Ann Surg 2014 0.95
18 MicroRNA-143 and -205 expression in neosquamous esophageal epithelium following Argon plasma ablation of Barrett's esophagus. J Gastrointest Surg 2009 0.92
19 Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: a prospective cohort study. Int J Clin Oncol 2011 0.89
20 Impact of gastro-esophageal reflux on mucin mRNA expression in the esophageal mucosa. J Gastrointest Surg 2008 0.88
21 miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus. World J Gastroenterol 2011 0.88
22 Laparoscopic antireflux surgery in the elderly. Surg Endosc 2007 0.85
23 Rising C-reactive protein and procalcitonin levels precede early complications after esophagectomy. J Gastrointest Surg 2015 0.83
24 Randomized trial of argon plasma coagulation versus endoscopic surveillance for barrett esophagus after antireflux surgery: late results. Ann Surg 2007 0.83
25 Endoscopic removal of self-expandable metal stents from the esophagus (with video). Gastrointest Endosc 2011 0.83
26 Improving the quality of pretreatment staging in patients with esophageal carcinoma - a fast track study. Acta Oncol 2011 0.82
27 Reoperation for dysphagia after cardiomyotomy for achalasia. Am J Surg 2007 0.81
28 Treatment and outcome of young patients with esophageal cancer in the Netherlands. J Surg Oncol 2013 0.81
29 The pathogenesis of Barrett's metaplasia and the progression to esophageal adenocarcinoma. Recent Results Cancer Res 2010 0.81
30 Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer. Ann Surg 2014 0.79
31 Defining a learning curve for laparoscopic cardiomyotomy. World J Surg 2008 0.79
32 The 30-day versus in-hospital and 90-day mortality after esophagectomy as indicators for quality of care. Ann Surg 2014 0.78
33 Inter- and intraobserver variation in the histopathological evaluation of early oesophageal adenocarcinoma. J Clin Pathol 2010 0.77
34 Location of lymph node involvement in patients with esophageal adenocarcinoma predicts survival. World J Surg 2014 0.77
35 P53 and SOX2 Protein Expression Predicts Esophageal Adenocarcinoma in Response to Neoadjuvant Chemoradiotherapy. Ann Surg 2017 0.76
36 Lymphatic micrometastases in patients with early esophageal adenocarcinoma. J Surg Oncol 2010 0.76
37 Reply to letter: "End-to-end versus end-to-side esophagogastrostomy after esophageal cancer resection: a prospective randomized study". Ann Surg 2014 0.75
38 Retrospective Multicenter Study on Risk Factors for Surgical Site Infections after Appendectomy for Acute Appendicitis. Dig Surg 2016 0.75
39 Reply to Letter: "Residual Esophageal Cancer After Neoadjuvant Chemoradiotherapy Frequently Involves the Mucosa and Submucosa". Ann Surg 2015 0.75
40 Barrett's esophagus: treatments of adenocarcinomas II. Ann N Y Acad Sci 2011 0.75
41 Patients' Preferences for Surgical Management of Esophageal Cancer: A Discrete Choice Experiment. World J Surg 2015 0.75
42 Identification of a 7.1-mega base pairs minimal deletion at 14q31.1-32.11 in adenocarcinomas of the gastroesophageal junction. Hum Pathol 2006 0.75
43 [Submucosal oesophageal tumours: diagnostics and treatment]. Ned Tijdschr Geneeskd 2012 0.75
44 Impact of Surgical Approach on Long-term Survival in Esophageal Adenocarcinoma Patients With or Without Neoadjuvant Chemoradiotherapy. Ann Surg 2017 0.75
45 P53 and SOX2 Protein Expression Predicts Esophageal Adenocarcinoma in Response to Neoadjuvant Chemoradiotherapy. Ann Surg 2016 0.75
46 Changes in diagnostic and treatment strategies of oesophageal cancer in the period from 2001 to 2009: a survey in the Netherlands. Eur J Gastroenterol Hepatol 2012 0.75
47 Increased resection rates and survival among patients aged 75 years and older with esophageal cancer: a Dutch nationwide population-based study. World J Surg 2012 0.75
48 Defining Benchmarks for Transthoracic Esophagectomy: A Multicenter Analysis of Total Minimally Invasive Esophagectomy in Low Risk Patients. Ann Surg 2017 0.75
49 Reply to "Neoadjuvant Therapy and Lymphadenectomy in Esophageal Cancer: Both Are Essential to Maximize Survival Benefit". Ann Surg 2017 0.75
50 [Pneumomediastinum: intervention is not always necessary]. Ned Tijdschr Geneeskd 2015 0.75
51 Comparison of Postoperative Outcomes Between Donation After Circulatory Death and Donation After Brain Death Liver Transplantation Using the Comprehensive Complication Index. Ann Surg 2017 0.75
52 Neuroendocrine in Barrett's mucosa and adenocarcinomas of the gastroesophageal junction. Int J Surg Pathol 2004 0.75
53 A Propensity Score Matched Analysis of Open Versus Minimally Invasive Transthoracic Esophagectomy in the Netherlands. Ann Surg 2017 0.75
54 Influence of young age on outcome after esophagectomy for cancer. World J Surg 2012 0.75